A message from Dr. Lou Jing
Since the establishment in 1993, we have successfully conducted the research, development and industrialization of four genetically engineered, protein-based products, and a few new product candidates are in the R&D or process of registration stages; we have established a quality control system in accordance with SFDA regulations and our manufacturing facilities fully comply with the Chinese GMP Guidelines which could produce for both clinical and commercial purposes; European Pharmacopoeia 2002 version on quality control has been implemented by us since 2004.
We maintain our sales and marketing forces in 31 provinces and major cities and continually expanding our targeted market through our 461 marketing & sales professionals and approximately 110 distributors, and have gained big market share in both volume and sales. The strong financial profile with a track record of growth and profitability is a good evidence to show that our company has entered into a stage of rapid development.
We should base on all of the above achievements and to accomplish further objectives. We will insist on the development direction of biotechnologies and carry on our specialization to develop new technologies and products with independent intellectual property.
Our goal is to become the leader in the research, development, manufacture and commercialization of protein-based therapeutics in China and continue to advance our drugs into international markets.
We believe that our leading position in the market, diverse portfolio of marketed products, proven research and development capabilities, nationwide sales and marketing network; high quality proprietary manufacturing processes and experienced and market-oriented management team will enable us to achieve our goals.
Dr. Lou Jing